BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25609198)

  • 1. The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
    McConnell EJ; Devapatla B; Yaddanapudi K; Davis KR
    Oncotarget; 2015 Mar; 6(7):4649-62. PubMed ID: 25609198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lunasin sensitivity in non-small cell lung cancer cells is linked to suppression of integrin signaling and changes in histone acetylation.
    Inaba J; McConnell EJ; Davis KR
    Int J Mol Sci; 2014 Dec; 15(12):23705-24. PubMed ID: 25530619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo.
    Cao MY; Lee Y; Feng NP; Al-Qawasmeh RA; Viau S; Gu XP; Lau L; Jin H; Wang M; Vassilakos A; Wright JA; Young AH
    J Pharmacol Exp Ther; 2004 Feb; 308(2):538-46. PubMed ID: 14610220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.
    Du Y; Gong J; Tian X; Yan X; Guo T; Huang M; Zhang B; Hu X; Liu H; Wang Y; Li J; Li M
    Tumour Biol; 2015 Sep; 36(10):7473-82. PubMed ID: 25908173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo.
    Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G
    Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Oxoolean-12-en-27-oic acid inhibits the proliferation of non-small cell lung carcinoma cells by inducing cell-cycle arrest at G0/G1 phase.
    Tae N; Seo J; Min BS; Ryoo S; Lee JH
    Anticancer Res; 2011 Jun; 31(6):2179-85. PubMed ID: 21737638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panaxydol Derived from Panax ginseng Inhibits G
    Lee JH; Leem DG; Chung KS; Kim KT; Choi SY; Lee KT
    Biol Pharm Bull; 2018; 41(11):1701-1707. PubMed ID: 30381670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
    Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
    J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY
    Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.
    Thangavel C; Boopathi E; Liu Y; McNair C; Haber A; Perepelyuk M; Bhardwaj A; Addya S; Ertel A; Shoyele S; Birbe R; Salvino JM; Dicker AP; Knudsen KE; Den RB
    Clin Cancer Res; 2018 Mar; 24(6):1402-1414. PubMed ID: 29311118
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model.
    Tang FY; Chiang EP; Pai MH
    J Agric Food Chem; 2010 Oct; 58(20):11156-64. PubMed ID: 20866043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; BarĂ³n AE; Zeng C; Johnson TK; Bunn PA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer.
    Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR
    Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
    Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
    Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators.
    Mateen S; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Mol Carcinog; 2010 Mar; 49(3):247-58. PubMed ID: 19908243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.